SI2059518T1 - Soli benzimidazolil piridil etrov in njihove formulacije - Google Patents

Soli benzimidazolil piridil etrov in njihove formulacije

Info

Publication number: SI2059518T1
Authority: SI; Slovenia
Prior art keywords: salts; formulations; pyridyl ethers; benzimidazolyl pyridyl; benzimidazolyl
Prior art date: 2006-08-30

Application number

SI200730587T

Other languages

English (en)

Inventor

Rampurna Gullapalli

Ahmad Hashash

Piotr H Karpinski

Kangwen L Lin

Eric M Loeser

Augustus O Okhamafe

Paul Allen Sutton

Eduardo Sy

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-30

Filing date

2007-08-30

Publication date

2011-06-30

2007-08-30 Application filed by Novartis Ag filed Critical Novartis Ag

2011-06-30 Publication of SI2059518T1 publication Critical patent/SI2059518T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Hematology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

SI200730587T 2006-08-30 2007-08-30 Soli benzimidazolil piridil etrov in njihove formulacije SI2059518T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US84117706P	2006-08-30	2006-08-30
US95446607P	2007-08-07	2007-08-07
EP07837588A EP2059518B1 (en)	2006-08-30	2007-08-30	Salts of benzimidazolyl pyridyl ethers and formulations thereof
PCT/US2007/019152 WO2008027523A2 (en)	2006-08-30	2007-08-30	Salts of benzimidazolyl pyridyl ethers and formulations thereof

Publications (1)

Publication Number	Publication Date
SI2059518T1 true SI2059518T1 (sl)	2011-06-30

Family

ID=39027583

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200730587T SI2059518T1 (sl)	2006-08-30	2007-08-30	Soli benzimidazolil piridil etrov in njihove formulacije

Country Status (33)

Country	Link
US (2)	US8202998B2 (sl)
EP (1)	EP2059518B1 (sl)
JP (1)	JP5279712B2 (sl)
KR (1)	KR20090043542A (sl)
CN (1)	CN101516870B (sl)
AT (1)	ATE504584T1 (sl)
AU (1)	AU2007290388B2 (sl)
BR (1)	BRPI0716243A2 (sl)
CA (1)	CA2660376C (sl)
CL (1)	CL2007002533A1 (sl)
CO (1)	CO6150180A2 (sl)
CY (1)	CY1112187T1 (sl)
DE (1)	DE602007013774D1 (sl)
DK (1)	DK2059518T3 (sl)
ES (1)	ES2360968T3 (sl)
GT (1)	GT200900045A (sl)
HR (1)	HRP20110311T1 (sl)
IL (1)	IL196811A (sl)
JO (1)	JO2702B1 (sl)
MA (1)	MA30711B1 (sl)
MX (1)	MX2009002279A (sl)
MY (1)	MY161829A (sl)
NO (1)	NO20091236L (sl)
NZ (1)	NZ574620A (sl)
PE (2)	PE20130814A1 (sl)
PL (1)	PL2059518T3 (sl)
PT (1)	PT2059518E (sl)
RU (1)	RU2457206C2 (sl)
SI (1)	SI2059518T1 (sl)
TN (1)	TN2009000068A1 (sl)
TW (1)	TW200819438A (sl)
WO (1)	WO2008027523A2 (sl)
ZA (1)	ZA200900664B (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20130814A1 (es) *	2006-08-30	2013-08-08	Novartis Ag	Sales de benzimidazolil piridil eteres y formulaciones que las contienen
BRPI0808526A2 (pt) *	2007-03-02	2014-08-19	Novartis Ag	Formas sólidas de um inibidor de raf cinase
JP2011524362A (ja) *	2008-06-13	2011-09-01	ノバルティスアーゲー	神経線維腫症用の置換ベンゾイミダゾール
TW201031406A (en) *	2009-01-29	2010-09-01	Novartis Ag	Substituted benzimidazoles for the treatment of astrocytomas
WO2011044072A1 (en)	2009-10-05	2011-04-14	Novartis Ag	Combination of raf-265 and an activator of ampk for use in the treatment of a proliferative disease
EP2645999A2 (en) *	2010-12-03	2013-10-09	Novartis AG	Pharmaceutical compositions
CN114727963B (zh) *	2019-12-02	2024-12-27	阿斯利康(瑞典)有限公司	6-(2-氯-6-甲基吡啶-4-基)-5-(4-氟苯基)-1,2,4-三嗪-3-胺的固体药物配制品
CN114478519B (zh) *	2020-10-23	2024-06-11	励缔(杭州)医药科技有限公司	吡唑并吡啶类化合物或其盐及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1499311T3 (da) *	2002-03-29	2010-03-08	Novartis Vaccines & Diagnostic	Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
US8299108B2 (en) *	2002-03-29	2012-10-30	Novartis Ag	Substituted benzazoles and methods of their use as inhibitors of raf kinase
US20060189619A1 (en)	2005-02-24	2006-08-24	Wyeth	3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
TW200804345A (en) *	2005-08-30	2008-01-16	Novartis Ag	Substituted benzimidazoles and methods of preparation
US7731795B2 (en)	2005-12-02	2010-06-08	Clemson University	Rhombohedral fluoroberyllium borate crystals and hydrothermal growth thereof for use in laser and non-linear optical applications and devices
JP2009544617A (ja) *	2006-07-21	2009-12-17	ノバルティスアクチエンゲゼルシャフト	ベンゾイミダゾリルピリジルエーテルの製剤
PE20130814A1 (es)	2006-08-30	2013-08-08	Novartis Ag	Sales de benzimidazolil piridil eteres y formulaciones que las contienen

2007
- 2007-08-29 PE PE2013000257A patent/PE20130814A1/es not_active Application Discontinuation
- 2007-08-29 PE PE2007001169A patent/PE20080766A1/es not_active Application Discontinuation
- 2007-08-30 PL PL07837588T patent/PL2059518T3/pl unknown
- 2007-08-30 EP EP07837588A patent/EP2059518B1/en active Active
- 2007-08-30 AU AU2007290388A patent/AU2007290388B2/en not_active Ceased
- 2007-08-30 JP JP2009526734A patent/JP5279712B2/ja not_active Expired - Fee Related
- 2007-08-30 DE DE602007013774T patent/DE602007013774D1/de active Active
- 2007-08-30 TW TW096132300A patent/TW200819438A/zh unknown
- 2007-08-30 JO JO2007364A patent/JO2702B1/en active
- 2007-08-30 CN CN2007800319886A patent/CN101516870B/zh not_active Expired - Fee Related
- 2007-08-30 AT AT07837588T patent/ATE504584T1/de active
- 2007-08-30 RU RU2009111384/04A patent/RU2457206C2/ru not_active IP Right Cessation
- 2007-08-30 PT PT07837588T patent/PT2059518E/pt unknown
- 2007-08-30 US US12/377,901 patent/US8202998B2/en not_active Expired - Fee Related
- 2007-08-30 CA CA2660376A patent/CA2660376C/en not_active Expired - Fee Related
- 2007-08-30 SI SI200730587T patent/SI2059518T1/sl unknown
- 2007-08-30 NZ NZ574620A patent/NZ574620A/en not_active IP Right Cessation
- 2007-08-30 WO PCT/US2007/019152 patent/WO2008027523A2/en not_active Ceased
- 2007-08-30 DK DK07837588.8T patent/DK2059518T3/da active
- 2007-08-30 KR KR1020097004220A patent/KR20090043542A/ko not_active Ceased
- 2007-08-30 MY MYPI20090433A patent/MY161829A/en unknown
- 2007-08-30 ES ES07837588T patent/ES2360968T3/es active Active
- 2007-08-30 BR BRPI0716243-0A patent/BRPI0716243A2/pt not_active IP Right Cessation
- 2007-08-30 HR HR20110311T patent/HRP20110311T1/hr unknown
- 2007-08-30 MX MX2009002279A patent/MX2009002279A/es active IP Right Grant
- 2007-08-30 CL CL200702533A patent/CL2007002533A1/es unknown
2009
- 2009-01-28 ZA ZA2009/00664A patent/ZA200900664B/en unknown
- 2009-01-29 IL IL196811A patent/IL196811A/en not_active IP Right Cessation
- 2009-02-23 CO CO09017888A patent/CO6150180A2/es unknown
- 2009-02-27 GT GT200900045A patent/GT200900045A/es unknown
- 2009-02-27 TN TN2009000068A patent/TN2009000068A1/fr unknown
- 2009-03-13 MA MA31711A patent/MA30711B1/fr unknown
- 2009-03-24 NO NO20091236A patent/NO20091236L/no not_active Application Discontinuation
2011
- 2011-07-04 CY CY20111100644T patent/CY1112187T1/el unknown
2012
- 2012-06-04 US US13/488,241 patent/US8501785B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK2059518T3 (da)	2011-05-16
TN2009000068A1 (en)	2010-08-19
ZA200900664B (en)	2009-12-30
US20100168060A1 (en)	2010-07-01
WO2008027523A3 (en)	2008-04-10
PL2059518T3 (pl)	2011-09-30
CL2007002533A1 (es)	2008-02-08
DE602007013774D1 (de)	2011-05-19
MY161829A (en)	2017-05-15
JP2010502622A (ja)	2010-01-28
EP2059518A2 (en)	2009-05-20
PE20130814A1 (es)	2013-08-08
WO2008027523A2 (en)	2008-03-06
CN101516870A (zh)	2009-08-26
CA2660376C (en)	2014-04-15
CN101516870B (zh)	2013-09-11
GT200900045A (es)	2010-06-14
US8202998B2 (en)	2012-06-19
BRPI0716243A2 (pt)	2013-09-03
ES2360968T3 (es)	2011-06-10
ATE504584T1 (de)	2011-04-15
AU2007290388A1 (en)	2008-03-06
CA2660376A1 (en)	2008-03-06
PT2059518E (pt)	2011-07-11
NO20091236L (no)	2009-03-27
TW200819438A (en)	2008-05-01
PE20080766A1 (es)	2008-06-15
RU2457206C2 (ru)	2012-07-27
HRP20110311T1 (hr)	2011-08-31
CO6150180A2 (es)	2010-04-20
JP5279712B2 (ja)	2013-09-04
MA30711B1 (fr)	2009-09-01
NZ574620A (en)	2011-05-27
US20120308651A1 (en)	2012-12-06
MX2009002279A (es)	2009-03-20
EP2059518B1 (en)	2011-04-06
CY1112187T1 (el)	2015-12-09
KR20090043542A (ko)	2009-05-06
HK1131613A1 (en)	2010-01-29
RU2009111384A (ru)	2010-10-10
IL196811A (en)	2013-03-24
AU2007290388B2 (en)	2011-07-14
JO2702B1 (en)	2013-03-03
IL196811A0 (en)	2009-11-18
US8501785B2 (en)	2013-08-06

Publication	Publication Date	Title
IL196811A0 (en)	2009-11-18	Salts of benzimidazolyl pyridyl ethers and formulations thereof
AU2009215514A9 (en)	2014-01-16	Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
NZ600801A (en)	2013-09-27	Substituted imidazopyridinyl-aminopyridine compounds
UA99129C2 (ru)	2012-07-25	Производные оксадиазола и их применение в качестве потенциирующих средств рецепторов глутамата
MX2009003323A (es)	2009-08-28	Eteres de celulosa cuaternizados para productos para el cuidado personal.
WO2012077136A3 (en)	2012-10-04	Process for the preparation of benzimidazole derivatives and its salts
WO2007098352A3 (en)	2007-10-25	Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
EA201390275A1 (ru)	2013-07-30	Кристаллический (r)-(e)-2-(4-(2-(5-(1-(3,5-дихлорпиридин-4-ил)этокси)-1h-индазол-3-ил)винил)-1h-пиразол-1-ил)этанол
EP2023926A4 (en)	2010-08-04	PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS
UA105000C2 (uk)	2014-04-10	ГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ СТЕАРОЇЛ-СоА-ДЕСАТУРАЗИ
ATE537809T1 (de)	2012-01-15	Reinigungszusammensetzungen zur körperpflege mit hydroxypropylmethylcellulose und alkylpolyglucosiden
EP2136639A4 (en)	2011-11-02	PYRID-2-YL-ANELLED HETEROCYCLIC COMPOUNDS, AND THEIR COMPOSITIONS AND USES
NO20075275L (no)	2007-12-27	Nye forbindelser
UY31947A (es)	2010-01-29	Procedimiento mejorado para la preparacion de 2-trifluorometil-5-(1-substituido)alquilpiridina
GEP20125649B (en)	2012-09-25	Benzimidazole compound crystal
IL200469A0 (en)	2010-04-29	Benzimidazole derivatives
MX2010001938A (es)	2010-03-11	Metodos para preparar compuestos basados en 4-fenil-6-(2,2,2-trifl uoro-1-feniletoxi)pirimidina.
MY152061A (en)	2014-08-15	Pyrrolopyrimidinecarboxamides
NO20073167L (no)	2007-09-27	Skjaerbeskyttende midler for isolering ved mikrofiltrering
MX345142B (es)	2017-01-18	Derivados de aminoalquilpirimidina como antagonistas del receptor h4 de histamina.
MX2010006253A (es)	2010-08-18	Proceso para la preparación de 5-(2-etil-dihidro-1h-inden-2-il)-1h -midazol y sales de los mismos.
IN2012DN00858A (sl)	2015-07-10
IN2012DN01223A (sl)	2015-04-10
AR062591A1 (es)	2008-11-19	Sales de benzimidazolil piridil eteres y formulaciones que las contienen
NI200700076A (es)	2008-03-07	Derivados piridinicos de indolin-2-ona, su preparacion y su aplicacion en terapeutica